Current Treatment approach to a mild to moderate atopic dermatitis patient

Speciality: Dermatology


Speaker:

Dr Aseem Sharma - Moderator MD, DNB, MBA, FAGE, IFAAD, Chief Dermatologist, | Skin Saga centre for Dermatology,

Dr Rajan T D - Speaker | MD, DVD, DNB, PGDMLS

Dr Brijesh Nair - Speaker | MD, HOD, Dept of Dermatology Command Hospital

Description:

A warm welcome to all the medical professionals in this interesting session on Current Treatment approach to a mild to moderate atopic dermatitis patient.

For patients with mild to moderate atopic dermatitis, the primary treatment approach focuses on moisturizing the skin. Regular use of emollients helps to restore the skin barrier, reducing dryness and irritation. Patients are encouraged to apply these moisturizers multiple times a day, especially after bathing.

Topical corticosteroids are commonly prescribed to manage inflammation and itching. These medications come in various strengths, allowing healthcare providers to tailor treatment based on the severity of the symptoms. Patients should apply the corticosteroids as directed, typically once or twice daily, for the best results.

In addition to corticosteroids, calcineurin inhibitors like tacrolimus or pimecrolimus can be used as an alternative treatment. These medications help reduce inflammation without the side effects associated with long-term steroid use. They are particularly useful for sensitive areas, such as the face and neck.

Therefore, get an overall knowledge of the current Treatment approach to a mild to moderate atopic dermatitis patient. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

5.

Two medications might work better for breast cancers that are resistant to one.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot